CONTEXT AND OBJECTIVE: The metabolic syndrome (MetS) indicates an increased cardiovascular risk. The objective of the present study was to determine the impact of the MetS and its individual traits on subclinical atherosclerosis, as measured with six noninvasive measurements of atherosclerosis (NIMA) in a 50- to 70-yr-old Dutch population-based cohort. Furthermore, we determined the impact of three different definitions of the MetS. DESIGN: We performed NIMA in 1517 participants of the Nijmegen Biomedical Study. The MetS was defined by definitions of the National Cholesterol Education Program, International Diabetes Federation, and the World Health Organization. RESULTS: Participants with the MetS (National Cholesterol Education Program) were characterized by increased subclinical atherosclerosis compared with participants without any trait of the MetS, as reflected by lower ankle-brachial index at rest [percent change (95% confidence interval), M: -5.2% (-9; -1), F: -3.1% (-6; -1)] and after exercise [M: -7.7% (-17;+2), F: -6.6% (-11; -2)], higher augmentation index [M: +4.8% (+3; +7), F: +1.9% (+4; +18)], increased pulse wave velocity [M: +22.8% (+15;+32), F: +20.5% (+14; +28)], increased intima-media thickness [M: +9.3% (+5; +13), F: +6.9% (+3; +11)], and thicker plaques [M: +17.6% (-2; +41), F: +26.6% (+5; +53)]. Most intriguingly, the number of traits was strongly associated with the severity of subclinical atherosclerosis because all NIMA gradually deteriorated with increasing number of traits present; NIMA were already deteriorated when one or two traits were present and further deteriorated when four or five traits of the MetS were present. Similar result were found when International Diabetes Federation and World Health Organization definitions of the MetS were used. CONCLUSIONS: For cardiovascular risk prediction, it is more important to take into account the presence of each individual trait and the number of traits of the MetS than to diagnose the presence of the MetS.
CONTEXT AND OBJECTIVE: The metabolic syndrome (MetS) indicates an increased cardiovascular risk. The objective of the present study was to determine the impact of the MetS and its individual traits on subclinical atherosclerosis, as measured with six noninvasive measurements of atherosclerosis (NIMA) in a 50- to 70-yr-old Dutch population-based cohort. Furthermore, we determined the impact of three different definitions of the MetS. DESIGN: We performed NIMA in 1517 participants of the Nijmegen Biomedical Study. The MetS was defined by definitions of the National Cholesterol Education Program, International Diabetes Federation, and the World Health Organization. RESULTS:Participants with the MetS (National Cholesterol Education Program) were characterized by increased subclinical atherosclerosis compared with participants without any trait of the MetS, as reflected by lower ankle-brachial index at rest [percent change (95% confidence interval), M: -5.2% (-9; -1), F: -3.1% (-6; -1)] and after exercise [M: -7.7% (-17;+2), F: -6.6% (-11; -2)], higher augmentation index [M: +4.8% (+3; +7), F: +1.9% (+4; +18)], increased pulse wave velocity [M: +22.8% (+15;+32), F: +20.5% (+14; +28)], increased intima-media thickness [M: +9.3% (+5; +13), F: +6.9% (+3; +11)], and thicker plaques [M: +17.6% (-2; +41), F: +26.6% (+5; +53)]. Most intriguingly, the number of traits was strongly associated with the severity of subclinical atherosclerosis because all NIMA gradually deteriorated with increasing number of traits present; NIMA were already deteriorated when one or two traits were present and further deteriorated when four or five traits of the MetS were present. Similar result were found when International Diabetes Federation and World Health Organization definitions of the MetS were used. CONCLUSIONS: For cardiovascular risk prediction, it is more important to take into account the presence of each individual trait and the number of traits of the MetS than to diagnose the presence of the MetS.
Authors: Lenny van Bon; Alsya J Affandi; Jasper Broen; Romy B Christmann; Renoud J Marijnissen; Lukasz Stawski; Giuseppina A Farina; Giuseppina Stifano; Allison L Mathes; Marta Cossu; Michael York; Cindy Collins; Mark Wenink; Richard Huijbens; Roger Hesselstrand; Tore Saxne; Mike DiMarzio; Dirk Wuttge; Sandeep K Agarwal; John D Reveille; Shervin Assassi; Maureen Mayes; Yanhui Deng; Joost P H Drenth; Jacqueline de Graaf; Martin den Heijer; Cees G M Kallenberg; Marc Bijl; Arnoud Loof; Wim B van den Berg; Leo A B Joosten; Vanessa Smith; Filip de Keyser; Rafaella Scorza; Claudio Lunardi; Piet L C M van Riel; Madelon Vonk; Waander van Heerde; Stephan Meller; Bernhard Homey; Lorenzo Beretta; Mark Roest; Maria Trojanowska; Robert Lafyatis; Timothy R D J Radstake Journal: N Engl J Med Date: 2013-12-18 Impact factor: 91.245
Authors: Patrick F McArdle; Brian W Whitcomb; Keith Tanner; Braxton D Mitchell; Alan R Shuldiner; Afshin Parsa Journal: BMC Cardiovasc Disord Date: 2012-03-14 Impact factor: 2.298
Authors: H M den Ruijter; S A E Peters; K A Groenewegen; T J Anderson; A R Britton; J M Dekker; G Engström; M J Eijkemans; G W Evans; J de Graaf; D E Grobbee; B Hedblad; A Hofman; S Holewijn; A Ikeda; M Kavousi; K Kitagawa; A Kitamura; H Koffijberg; M A Ikram; E M Lonn; M W Lorenz; E B Mathiesen; G Nijpels; S Okazaki; D H O'Leary; J F Polak; J F Price; C Robertson; C M Rembold; M Rosvall; T Rundek; J T Salonen; M Sitzer; C D A Stehouwer; J C Witteman; K G Moons; M L Bots Journal: Diabetologia Date: 2013-04-09 Impact factor: 10.122
Authors: Michiel L Bots; Karlijn A Groenewegen; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Gunnar Engström; Greg W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; M Arfan Ikram; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jacqueline F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Oscar H Franco; Sanne A E Peters; Hester M den Ruijter Journal: Hypertension Date: 2014-03-10 Impact factor: 10.190
Authors: Martine T P Besouw; Suzanne Holewijn; Elena N Levtchenko; Mirian C H Janssen Journal: J Inherit Metab Dis Date: 2011-02-09 Impact factor: 4.982
Authors: Junichi Yatabe; Midori S Yatabe; Minoru Yoneda; Robin A Felder; Pedro A Jose; Hironobu Sanada Journal: Int J Hypertens Date: 2012-02-21 Impact factor: 2.420
Authors: Tessel E Galesloot; Luc L Janss; Stephen Burgess; Lambertus A L M Kiemeney; Martin den Heijer; Jacqueline de Graaf; Suzanne Holewijn; Beben Benyamin; John B Whitfield; Dorine W Swinkels; Sita H Vermeulen Journal: BMC Genet Date: 2015-07-11 Impact factor: 2.797